General Information
Version
1.1
Revision date
2024-07-29
Product name
Zellulin ZelluGEN
Emergency telephone
+65 9066 3965, 0845 46 47, +353 1 809 2566, 1 809 2166
Icons in SDS
Company Information
company name
Avant Proteins, Ltd
e-mail address of the competent person responsible for the Safety Data Sheet
enquiry@zellulin.tech
Section 2
2.3 Other hazards
Contains no PBT and/or vPvB substances ≥ 0.1% assessed in accordance with REACH Annex XIII The mixture does not contain substance(s) included in the list established in accordance with Article 59(1) of REACH for having endocrine disrupting properties, or substance(s) are not identified as having endocrine disrupting properties in accordance with the criteria set out in Commission Delegated Regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 at a concentration equal to or greater than 0,1 %
2.1 Classification of the substance or mixture
Classification according to Regulation (EC) No. 1272/2008 [CLP] Not classified Adverse physicochem ical, hum an health and environm ental effects To our knowledge, this product does not present any particular risk, provided it is handled in accordance with good occupational hygiene and safety practice.
